A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma

We’d like to hear from you. If you have any questions or comments, please fill out the brief form below, and one of our friendly representatives will be in touch.